{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:05:52Z","timestamp":1765609552947},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,11,21]],"date-time":"2012-11-21T00:00:00Z","timestamp":1353456000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00115-012-3680-9","type":"journal-article","created":{"date-parts":[[2012,11,20]],"date-time":"2012-11-20T01:57:35Z","timestamp":1353376655000},"page":"1600-1608","source":"Crossref","is-referenced-by-count":22,"title":["Therapie und Versorgung bei chronischer Migr\u00e4ne","Therapy and care of patients with chronic migraine"],"prefix":"10.1007","volume":"83","author":[{"given":"A.","family":"Straube","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gaul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"F\u00f6rderreuther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Kropp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Marziniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Evers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.H.","family":"Jost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"G\u00f6bel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lampl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.S.","family":"S\u00e1ndor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.R.","family":"Gantenbein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-C.","family":"Diener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,21]]},"reference":[{"key":"3680_CR1","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1526-4610.2005.05108.x","volume":"45","author":"Aurora","year":"2005","unstructured":"Aurora SK, Barrodale P, Chronicle EP, Mulleners WM (2005) Cortical inhibition is reduced in chronic and episodic migraine and demonstrates a spectrum of illness. Headache 45:546\u2013552","journal-title":"Headache"},{"key":"3680_CR2","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1526-4610.2007.00853.x","volume":"47","author":"Aurora","year":"2007","unstructured":"Aurora SK, Barrodale PM, Tipton RL, Khodavirdi A (2007) Brainstem dysfunction in chronic migraine as evidenced by neurophysiological and positron emission tomography studies. Headache 47:996\u20131007","journal-title":"Headache"},{"key":"3680_CR3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/0333102410364676","volume":"30","author":"Aurora","year":"2010","unstructured":"Aurora SK, Dodick DW, Turkel CC et al (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of PREEMPT 1 trial. Cephalalgia 30:793\u2013803","journal-title":"Cephalalgia"},{"key":"3680_CR4","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1526-4610.2011.01990.x","volume":"51","author":"Aurora","year":"2011","unstructured":"Aurora SK, Winner P, Freeman MC et al (2011) OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-Week PREEMPT clinical program. Headache 51:1358\u20131373","journal-title":"Headache"},{"key":"3680_CR5","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/WCO.0b013e32832ae61e","volume":"22","author":"Bartsch","year":"2009","unstructured":"Bartsch T, Paemeleire K, Goadsby PJ (2009) Neurostimulation approaches to primary headache disorders. Curr Opin Neurol 22:262\u2013268","journal-title":"Curr Opin Neurol"},{"key":"3680_CR6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.wnf.0000192136.46145.44","volume":"28","author":"Bartolini","year":"2005","unstructured":"Bartolini M, Silvestrini M, Taffi R et al (2005) Efficacy of topiramate and valproate in chronic migraine. Clin Neuropharmacol 28:277\u2013279","journal-title":"Clin Neuropharmacol"},{"key":"3680_CR7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1468-2982.2004.00691.x","volume":"24","author":"Bigal","year":"2004","unstructured":"Bigal ME, Rapoport AM, Sheftell FD et al (2004) Transformed migraine and medication overuse in a tertiary headache centre\u2013clinical characteristics and treatment outcomes. Cephalalgia 24:483\u2013490","journal-title":"Cephalalgia"},{"key":"3680_CR8","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1526-4610.2005.05112.x","volume":"45","author":"Bigal","year":"2005","unstructured":"Bigal ME, Rapoport AM, Tepper SJ et al (2005) The classification of chronic daily headache in adolescents\u2013a comparison between the second edition of the international classification of headache disorders and alternative diagnostic criteria. Headache 45:582\u2013589","journal-title":"Headache"},{"key":"3680_CR9","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1212\/01.wnl.0000262045.11646.b1","volume":"68","author":"Bigal","year":"2007","unstructured":"Bigal ME, Lipton RB, Holland PR, Goadsby PJ (2007) Obesity, migraine, and chronic migraine: possible mechanisms of interaction. Neurology 68:1851\u20131861","journal-title":"Neurology"},{"key":"3680_CR10","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1526-4610.2008.01217.x","volume":"48","author":"Bigal","year":"2008","unstructured":"Bigal ME, Serrano D, Buse D et al (2008) Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 48:1157\u20131168","journal-title":"Headache"},{"key":"3680_CR11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/WCO.0b013e328300c6f5","volume":"21","author":"Bigal","year":"2008","unstructured":"Bigal ME, Lipton RB (2008) The prognosis of migraine. Curr Opin Neurol 21:301\u2013308","journal-title":"Curr Opin Neurol"},{"key":"3680_CR12","first-page":"145","volume":"8","author":"Bigal","year":"2009","unstructured":"Bigal M (2009) Migraine chronification\u2013concept and risk factors. Discov Med 8:145\u2013150","journal-title":"Discov Med"},{"key":"3680_CR13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10194-012-0460-7","volume":"13","author":"Bloudek","year":"2012","unstructured":"Bloudek LM, Stokes M, Buse DC et al (2012) Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS). J Headache Pain 13:361\u2013378","journal-title":"J Headache Pain"},{"key":"3680_CR14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1526-4610.2007.00949.x","volume":"48","author":"Blumenfeld","year":"2008","unstructured":"Blumenfeld AM, Schim JD, Chippendale TJ (2008) Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine. Headache 48:210\u2013220","journal-title":"Headache"},{"key":"3680_CR15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1526-4610.2010.01796.x","volume":"51","author":"Cady","year":"2011","unstructured":"Cady RK, Schreiber CP, Porter JA et al (2011) A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine. Headache 51:21\u201332","journal-title":"Headache"},{"key":"3680_CR16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10072-009-0073-3","volume":"30","author":"Cecchini","year":"2009","unstructured":"Cecchini AP, Mea E, Tullo V et al (2009) Vagus nerve stimulation in drug-resistant daily chronic migraine with depression: preliminary data. Neurol Sci 30(Suppl 1):101\u2013104","journal-title":"Neurol Sci"},{"key":"3680_CR17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1526-4610.2008.01257.x","volume":"49","author":"Cevoli","year":"2009","unstructured":"Cevoli S, Sancisi E, Grimaldi D et al (2009) Family history for chronic headache and drug overuse as a risk factor for headache chronification. Headache 49:412\u2013418","journal-title":"Headache"},{"key":"3680_CR18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1526-4610.2010.01800.x","volume":"51","author":"Couch","year":"2011","unstructured":"Couch JR (2011) Amitriptyline in the prophylactic treatment of migraine and chronic daily headache. Headache 51:33\u201351","journal-title":"Headache"},{"key":"3680_CR19","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1468-2982.2007.01326.x","volume":"27","author":"Diener","year":"2007","unstructured":"Diener HC, Bussone G, Van Oene JC et al (2007) Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 27:814\u2013823","journal-title":"Cephalalgia"},{"key":"3680_CR20","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S1474-4422(07)70272-7","volume":"6","author":"Diener","year":"2007","unstructured":"Diener HC, Agosti R, Allais G et al (2007) Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial. Lancet Neurol 6:1054\u20131062","journal-title":"Lancet Neurol"},{"key":"3680_CR21","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/0333102410364677","volume":"30","author":"Diener","year":"2010","unstructured":"Diener HC, Dodick DW, Aurora SK et al (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of PREEMPT 2 trial. Cephalalgia 30:804\u2013814","journal-title":"Cephalalgia"},{"key":"3680_CR22","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1177\/0333102411409075","volume":"31","author":"Diener","year":"2011","unstructured":"Diener HC, Gaul C, Jensen R et al (2011) Integrated headache care. Cephalalgia 31:1039\u20131047","journal-title":"Cephalalgia"},{"key":"3680_CR23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/0333102411425867","volume":"32","author":"Diener","year":"2012","unstructured":"Diener HC (2012) Detoxification for medication overuse headache is not necessary. Cephalalgia 32:423\u2013427","journal-title":"Cephalalgia"},{"key":"3680_CR24","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1526-4610.2010.01678.x","volume":"50","author":"Dodick","year":"2010","unstructured":"Dodick DW, Turkel CC, Degryse RE et al (2010) OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 50:921\u2013936","journal-title":"Headache"},{"key":"3680_CR25","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1055\/s-0038-1627343","volume":"27","author":"Evers","year":"2008","unstructured":"Evers S, May A, Fritsche G et al (2008) Akuttherapie und Prophylaxe der Migr\u00e4ne. Leitlinie der Deutschen Migr\u00e4ne- und Kopfschmerzgesellschaft und der Deutschen Gesellschaft f\u00fcr Neurologie. Nervenheilkunde 27:933\u2013949","journal-title":"Nervenheilkunde"},{"key":"3680_CR26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1526-4610.2007.00963.x","volume":"48","author":"Freitag","year":"2008","unstructured":"Freitag FG, Diamond S, Diamond M, Urban G (2008) Botulinum Toxin Type A in the treatment of chronic migraine without medication overuse. Headache 48:201\u2013209","journal-title":"Headache"},{"key":"3680_CR27","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1471-2377-11-124","volume":"11","author":"Gaul","year":"2011","unstructured":"Gaul C, Br\u00f6mstrup J, Fritsche G et al (2011) Evaluating integrated headache care: a one-year follow-up observational study in patients treated at the Essen headache centre. BMC Neurol 11:124","journal-title":"BMC Neurol"},{"key":"3680_CR28","first-page":"475","volume":"12","author":"Gaul","year":"2011","unstructured":"Gaul C, Doorn C van, Webering N et al (2011) Clinical outcome of a headache specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center. An observational study. TJHP 12:475\u2013483","journal-title":"TJHP"},{"key":"3680_CR29","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1526-4610.2011.01872.x","volume":"51","author":"Goadsby","year":"2011","unstructured":"Goadsby PJ (2011) New daily persistent headache: a syndrome not a discrete disorder. Headache 51:650\u2013653","journal-title":"Headache"},{"key":"3680_CR30","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00482-009-0857-7","volume":"23","author":"G\u00f6bel","year":"2009","unstructured":"G\u00f6bel H, Heinze A, Heinze-Kuhn K et al (2009) Entwicklung und Umsetzung der integrierten Versorgung in der Schmerztherapie. Das bundesweite Kopfschmerzbehandlungsnetz. Schmerz 23:653\u2013670","journal-title":"Schmerz"},{"key":"3680_CR31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00482-011-1084-6","volume":"25","author":"G\u00f6bel","year":"2011","unstructured":"G\u00f6bel H, Heinze A (2011) Prophylaxe der chronischen Migr\u00e4ne mit Botulinumtoxin Typ A. Schmerz 25:563\u2013571","journal-title":"Schmerz"},{"key":"3680_CR32","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00482-011-1085-5","volume":"25","author":"G\u00f6bel","year":"2011","unstructured":"G\u00f6bel H, Heinze A (2011) Chronische Migr\u00e4ne und Kopfschmerz bei Medikamenten\u00fcbergebrauch. Schmerz 25:493\u2013500","journal-title":"Schmerz"},{"key":"3680_CR33","unstructured":"Headache Classification Subcommittee of the International Headache Society (2004). The International Classificatiopn of Headache Disorders, 2. Aufl. Cephalalgia, Bd\u00a024, S\u00a01\u2013160"},{"key":"3680_CR34","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1468-2982.2006.01172.x","volume":"26","author":"Headache","year":"2006","unstructured":"Headache Classification Committee, Olesen J, Bousser MG et al (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26:742\u2013746","journal-title":"Cephalalgia"},{"key":"3680_CR35","doi-asserted-by":"crossref","first-page":"c4871","DOI":"10.1136\/bmj.c4871","volume":"341","author":"Holroyd","year":"2010","unstructured":"Holroyd KA, Cottrell CK, O\u2019Donnell FJ et al (2010) Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial. BMJ 341:c4871. DOI 10.1136\/bmj.c4871","journal-title":"BMJ"},{"key":"3680_CR36","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.2012.505","volume":"307","author":"Jackson","year":"2012","unstructured":"Jackson JL, Kuriyama A, Hayashino Y (2012) Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis. JAMA 307:1736\u20131745","journal-title":"JAMA"},{"key":"3680_CR37","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1177\/0333102410361403","volume":"30","author":"Jensen","year":"2010","unstructured":"Jensen R, Zeeberg P, Dehlendorf C, Olesen J (2010) Predictors of outcome of a multidisciplinary programme in a multidisciplinary headache center. Cephalalgia 30:1214\u20131224","journal-title":"Cephalalgia"},{"key":"3680_CR38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11916-011-0233-z","volume":"16","author":"Katsarava","year":"2012","unstructured":"Katsarava Z, Buse DC, Manack AN, Lipton RB (2012) Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep 16:86\u201392","journal-title":"Curr Pain Headache Rep"},{"key":"3680_CR39","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1590\/S0004-282X2000000300006","volume":"58","author":"Krymchantowski","year":"2000","unstructured":"Krymchantowski AV (2000) Naproxen sodium decreases migraine recurrence when administered with sumatriptan. Arq Neuropsiquiatr 58(2B):428\u2013430","journal-title":"Arq Neuropsiquiatr"},{"key":"3680_CR40","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1046\/j.1526-4610.2002.02125.x","volume":"42","author":"Krymchantowski","year":"2002","unstructured":"Krymchantowski AV, Silva MT, Barbosa JS, Alves LA (2002) Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study. Headache 42:510\u2013514","journal-title":"Headache"},{"key":"3680_CR41","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1468-2982.2007.01426.x","volume":"27","author":"Lant\u00e9ri-Minet","year":"2007","unstructured":"Lant\u00e9ri-Minet M, Massiou H, Nachit-Ouinekh F et al (2007) The GRIM2005 study of migraine consultation in France I. Determinants of consultation for migraine headache in France. Cephalalgia 27:1386\u20131397","journal-title":"Cephalalgia"},{"key":"3680_CR42","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1212\/WNL.59.7.1011","volume":"59","author":"Limmroth","year":"2002","unstructured":"Limmroth V, Katsarava Z, Fritsche G et al (2002) Features of medication overuse headache following overuse of different acute headache drugs. Neurology 59:1011\u20131014","journal-title":"Neurology"},{"key":"3680_CR43","first-page":"CD001218","volume":"1","author":"Linde","year":"2009","unstructured":"Linde K, Allais G, Brinkhaus B et al (2009) Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev 1:CD001218","journal-title":"Cochrane Database Syst Rev"},{"key":"3680_CR44","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1212\/WNL.0b013e318232ab65","volume":"77","author":"Lipton","year":"2011","unstructured":"Lipton RB, Varon SF, Grosberg B et al (2011) OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine. Neurology 77:1465\u20131472","journal-title":"Neurology"},{"key":"3680_CR45","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.clineuro.2010.02.004","volume":"112","author":"Magalh\u00e3es","year":"2010","unstructured":"Magalh\u00e3es E, Menezes C, Cardeal M, Melo A (2010) Botulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine. Clin Neurol Neurosurg 112:463\u2013466","journal-title":"Clin Neurol Neurosurg"},{"key":"3680_CR46","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1526-4610.2005.05066.x","volume":"45","author":"Mathew","year":"2005","unstructured":"Mathew NT, Frishberg BM, Gawel M et al (2005) Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache 45:293\u2013307","journal-title":"Headache"},{"key":"3680_CR47","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1111\/j.1526-4610.2009.01566.x","volume":"49","author":"Mathew","year":"2009","unstructured":"Mathew NT, Jaffri SF (2009) A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study. Headache 49:1466\u20131478","journal-title":"Headache"},{"key":"3680_CR48","doi-asserted-by":"crossref","unstructured":"Mo\u2019tamedi H, Rezaiemaram P, Tavallaie A (2012) The effectiveness of a group-based acceptance and commitment additive therapy on rehabilitation of female outpatients with chronic headache: preliminary findings reducing 3 dimensions of headache impact. Headache DOI 10.1111\/j.1526-4610.2012.02192.x. [Epub ahead of print]","DOI":"10.1111\/j.1526-4610.2012.02192.x"},{"key":"3680_CR49","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1526-4610.2009.01369.x","volume":"49","author":"Munakata","year":"2009","unstructured":"Munakata J, Hazard E, Serrano D et al (2009) Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache 49:498\u2013508","journal-title":"Headache"},{"key":"3680_CR50","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1468-2982.2009.01941.x","volume":"30","author":"Natoli","year":"2010","unstructured":"Natoli JL, Manack A, Dean B et al (2010) Global prevalence of chronic migraine: a systematic review. Cephalalgia 30:599\u2013609","journal-title":"Cephalalgia"},{"key":"3680_CR51","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1468-2982.2004.00641.x","volume":"24","author":"Ondo","year":"2004","unstructured":"Ondo WG, Vuong KD, Derman HS (2004) Botulinum toxin A for chronic daily headache: a randomized, placebo-controlled, parallel design study. Cephalalgia 24:60\u201365","journal-title":"Cephalalgia"},{"key":"3680_CR52","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1007\/s00415-002-0834-x","volume":"249","author":"Ozturk","year":"2002","unstructured":"Ozturk V, Cakmur R, Donmez B et al (2002) Comparison of cortical excitability in chronic migraine (transformed migraine) and migraine without aura. A transcranial magnetic stimulation study. J Neurol 249:1268\u20131271","journal-title":"J Neurol"},{"key":"3680_CR53","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1468-2982.2007.01499.x","volume":"28","author":"Rueda-S\u00e1nchez","year":"2008","unstructured":"Rueda-S\u00e1nchez M, D\u00edaz-Mart\u00ednez LA (2008) Prevalence and associated factors for episodic and chronic daily headache in the Colombian population. Cephalalgia 28:216\u2013225","journal-title":"Cephalalgia"},{"key":"3680_CR54","first-page":"271","volume":"3","author":"Saper","year":"2010","unstructured":"Saper JR, Dodick DW, Silberstein SD et al (2010) Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia 3:271\u2013285","journal-title":"Cephalalgia"},{"key":"3680_CR55","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3959(03)00293-8","volume":"106","author":"Scher","year":"2003","unstructured":"Scher AI, Stewart WF, Ricci JA, Lipton RB (2003) Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 106:81\u201389","journal-title":"Pain"},{"key":"3680_CR56","doi-asserted-by":"crossref","first-page":"245","DOI":"10.36076\/ppj.2012\/15\/245","volume":"15","author":"Serra","year":"2012","unstructured":"Serra G, Marchioretto F (2012) Occipital nerve stimulation for chronic migraine: a randomized trial. Pain Physician 15:245\u2013253","journal-title":"Pain Physician"},{"key":"3680_CR57","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1212\/WNL.47.4.871","volume":"47","author":"Silberstein","year":"1996","unstructured":"Silberstein SD, Lipton RB, Sliwinski M (1996) Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 47:871\u2013875","journal-title":"Neurology"},{"key":"3680_CR58","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.4065\/80.9.1126","volume":"80","author":"Silberstein","year":"2005","unstructured":"Silberstein SD, Stark SR, Lucas SM et al (2005) Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Mayo Clin Proc 80:1126\u20131137","journal-title":"Mayo Clin Proc"},{"key":"3680_CR59","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1526-4610.2006.00684.x","volume":"47","author":"Silberstein","year":"2007","unstructured":"Silberstein SD, Lipton RB, Dodick DW et al (2007) Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache 47:170\u2013180","journal-title":"Headache"},{"key":"3680_CR60","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1212\/WNL.0b013e31824d5846","volume":"78","author":"Silberstein","year":"2012","unstructured":"Silberstein SD, Dodick DW, Lindblad AS et al (2012) Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraine. Neurology 78:976\u2013984","journal-title":"Neurology"},{"key":"3680_CR61","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1212\/01.WNL.0000100121.58594.11","volume":"61","author":"Spira","year":"2003","unstructured":"Spira PJ, Beran RG (2003) Australian gabapentin chronic daily headache group. Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study. Neurology 61:1753\u20131759","journal-title":"Neurology"},{"key":"3680_CR62","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00482-008-0645-9","volume":"22","author":"Straube","year":"2008","unstructured":"Straube A, May A, Kropp P et al (2008) Therapie prim\u00e4rer chronischer Kopfschmerzen. Chronische Migr\u00e4ne, chronischer Kopfschmerz vom Spannungstyp und andere chronische t\u00e4gliche Kopfschmerzen. Schmerz 22:531\u2013543","journal-title":"Schmerz"},{"key":"3680_CR63","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/0333102409355603","volume":"30","author":"Straube","year":"2010","unstructured":"Straube A, Pfaffenrath V, Ladwig KH et al (2010) Prevalence of chronic migraine and medication overuse headache in Germany\u2013the German DMKG headache study. Cephalalgia 30:207\u2013213","journal-title":"Cephalalgia"},{"key":"3680_CR64","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-0030-1248609","volume":"37","author":"Straube","year":"2010","unstructured":"Straube A (2010) Botulinumtoxin bei Kopfschmerzen: Ende eines langen Weges? Akt Neurol 37:327\u2013332","journal-title":"Akt Neurol"},{"key":"3680_CR65","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1526-4610.2009.01557.x","volume":"50","author":"Tietjen","year":"2010","unstructured":"Tietjen GE, Brandes JL, Peterlin BL et al (2010) Childhood maltreatment and migraine (part II). Emotional abuse as a risk factor for headache chronification. Headache 50:32\u201341","journal-title":"Headache"},{"key":"3680_CR66","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1526-4610.2009.01556.x","volume":"50","author":"Tietjen","year":"2010","unstructured":"Tietjen GE, Brandes JL, Peterlin BL et al (2010) Childhood maltreatment and migraine (part I). Prevalence and adult revictimization: a multicenter headache clinic survey. Headache 50:20\u201331","journal-title":"Headache"},{"key":"3680_CR67","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10194-010-0286-0","volume":"12","author":"Winter","year":"2011","unstructured":"Winter AC, Hoffmann W, Meisinger C et al (2011) Association between lifestyle factors and headache. J Headache Pain 12:147\u2013155","journal-title":"J Headache Pain"},{"key":"3680_CR68","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1177\/0333102411420585","volume":"31","author":"Yang","year":"2011","unstructured":"Yang CP, Chang MH, Liu PE et al (2011) Acupuncture vs. Topiramate in chronic migraine prophylaxis. Cephalalgia 31:1510\u20131521","journal-title":"Cephalalgia"},{"key":"3680_CR69","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10194-008-0002-5","volume":"9","author":"Yurekli","year":"2008","unstructured":"Yurekli VA, Akhan G, Kutluhan S et al (2008) The effect of sodium valproate on chronic daily headache and its subgroups. J Headache Pain 9:37\u201341","journal-title":"J Headache Pain"},{"key":"3680_CR70","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1212\/01.wnl.0000217914.30994.bd","volume":"66","author":"Zeeberg","year":"2006","unstructured":"Zeeberg P, Olesen J, Jensen R (2006) Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology 66:1894\u20131898","journal-title":"Neurology"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-012-3680-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-012-3680-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-012-3680-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T14:51:18Z","timestamp":1714575078000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-012-3680-9"}},"subtitle":["Expertenempfehlung der Deutschen Migr\u00e4ne- und Kopfschmerzgesellschaft\/Deutsche Gesellschaft f\u00fcr Neurologie sowie der \u00d6sterreichischen Kopfschmerzgesellschaft\/Schweizerischen Kopfwehgesellschaft","Expert recommendations of the German Migraine and Headache Society\/German Society for Neurology as well as the Austrian Headache Society\/Swiss Headache Society"],"short-title":[],"issued":{"date-parts":[[2012,11,21]]},"references-count":70,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["3680"],"URL":"https:\/\/doi.org\/10.1007\/s00115-012-3680-9","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,21]]}}}